The Fetal Medicine Foundation 15th World Congress in Fetal Medicine
Abstracts
 
  • Aneuploidies
  • cfDNA test
  • Defects
    • CNS
    • High NT
    • Syndromes
    • Placenta
    • Other
    • All
    • Face
    • Heart
    • Lungs
    • Abdominal wall
    • Gastrointestinal
    • Renal
    • Skeleton
    • Tumors
  • Fetal therapy
  • Impaired placentation
  • Congenital infections
  • GDM / obesity
  • Maternal conditions
  • Preterm birth
  • Labour / delivery
  • Multiple pregnancies
  • Other

Impaired placentation

  1. Outcomes of fetuses with decreasing growth trajectory but are born Appropriate for Gestational age View pdf
  2. Pilot programme: turning the Pyramid of prenatal care in the Zone Military Hospital, Tabasco, Mexico View pdf
  3. Differences in brain metabolism in term and preterm-born small neonates assessed by MR Spectroscopy View pdf
  4. The symmetric intra-uterine growth restriction: what balance etiological asks and what in prenatal care? View pdf
  5. Birth weight in relation to health and disease in later life: review of systematic reviews and meta-analyses View pdf
  6. Fetal death and placental weight View pdf
  7. Two cases of trisomy 13 and pre-eclampsia View pdf
  8. Fiest trimester placental growth factor in combined screening of aneuplodies and preeclampsia View pdf
  9. Value of placental volume and vascular flow indices in 1st trimester prediction of PE and SGA View pdf
  10. Intrauterine growth restriction (IUGR) - A challenge of modern obstetrics ultrasound View pdf
  11. Maternal obesity on pregnancy outcomes in women with severe preeclampsia View pdf
  12. Importance of timing first trimester PlGF in screening for PE View pdf
  13. Determining gestational age using genome methylation profile View pdf
  14. Maternal and perinatal outcomes in early onset and late onset preeclampsia View pdf
  15. The obstetric outcomes in women with pure preeclampsia and superimposed preeclampsia View pdf
  16. Maternal and perinatal outcomes in women with chronic hypertension and risk factors of PE View pdf
  17. Hemodynamic Effects of Corticosteroids in Appropriate for Gestational Age and Growth Restricted Fetuses View pdf
  18. Repeatability and reproducibility of 3rd trimester uterine arteries and middle cerebral artery PI View pdf
  19. Next Generation Sequencing to 1st trimester maternal white blood cells to discover new genes implicated in PE View pdf
  20. Early-onset intrauterine growth restriction: predictions factors to diagnosis View pdf
  21. Late-onset intrauterine growth restriction: predictions factors to diagnosis View pdf
  22. Neural injury markers in intrauterine growth restriction and its relation to perinatal outcomes View pdf
  23. Role of mean blood pressure in screening for PE and SGA in the first trimester View pdf
  24. Preeclampsia: RCT of argininine for prevention View pdf
  25. Neonatal outcomes and abnormalities in transfontanellar ultrasound in FGR fetuses with abnormal UA View pdf
  26. Determination of PAPP-A in early-and late-onset small for gestational age fetuses View pdf
  27. The cerebral placental ratio and obstetrics and neonatal outcomes in small for gestational age fetuses View pdf
  28. Impact of social and economic status on newborn weight View pdf
  29. Quantification of fetal microchimerism during pregnancy: a tool for health prediction? View pdf
  30. Predicting fetal weight: The bio-ellipse model View pdf
  31. Transgenerational effects of fetal growth restriction View pdf
  32. Reproducibility of fractional area change in the assessment of fetal right ventricle systolic function View pdf
  33. Assisted reproductive technologies and fetal cardiovascular remodeling persistence: a follow up study View pdf
  34. Perinatal effects of Nutritional Intrauterine Therapy in a Rabbit Model of Intrauterine Growth Restriction View pdf
  35. Short femur lenght at 20 weeks scan as a predictor of subsequent develop of preeclampsia View pdf
  36. Correlation between uterine artery Doppler sonography and severity of pre-eclampsia & fetal distress View pdf
  37. Different patterns of cardiac remodeling among fetuses with growth restriction View pdf
  38. External iliac artery Doppler assessment in the prediction of adverse pregnancy outcomes View pdf
  39. Cardiometabolic risk in preadolescents who suffered fetal growth restriction View pdf
  40. Primary electrical remodeling due to fetal growth restriction at preadolescent age View pdf
  41. Fetal growth restriction and cardiac remodeling at preadolescent age View pdf
  42. Performance of a 3rd combined screening model for the prediction of adverse perinatal outcome View pdf
  43. Prediction of FGR using estimated fetal weight versus a combined screening model at 34 weeks View pdf
  44. Pattern of placental lesions in small for gestational age cases View pdf
  45. Neurobehavioral outcomes in fetal growth restriction vs small-for-gestational age View pdf
  46. Glucocorticoids in treatment of HELLP syndrome View pdf
  47. Association of (Pro)renin receptor gene polymorphism with hypertensive disorders of pregnancy View pdf
  48. First trimester screening for preeclampsia using FMF algorithm View pdf
  49. First-trimester Metabolomic Prediction of Subsequent Stillbirth View pdf
  50. Forms of luteinizing hormone HCG receptor for 1st trimester prediction of early and late PE View pdf
  51. Can placental histopathology lesions predict recurrence of preeclampsia? View pdf
  52. Transient fetal blood redistribution associated with maternal supine position View pdf
  53. Lean before pregnancy View pdf
  54. First Trimester uterine artery Doppler as a predictor of pre-eclampsia View pdf
  55. Maternal clinical characteristics as predictors of pre-eclampsia View pdf
  56. Sonographic estimated fetal weight by different formulas: Does fetal presentation matter? View pdf
  57. First trimester serum markers to predict pregnancy complications: Tunisian prospective study View pdf
  58. Polymorphism in the promoter region of PP13 is associated with increased risk for PE View pdf
  59. Preeclampsia: abnormal vascular architecture at the placental-maternal interface View pdf
  60. Pregnancy outcomes associated with low PAPP-A levels View pdf
  61. The uterine artery Doppler between 11 to 14 weeks of pregnancy in pre-eclampsia prediction View pdf
  62. Prediction of intrauterine growth restriction by uterine arteries Doppler in the first trimester View pdf
  63. Reduced level of PP13 in syncytiotrophoblast extracellular vesicles of PE patients at delivery View pdf
  64. Sonographic prediction of small and large for gestational age in breech presenting fetuses View pdf
  65. MRI detects of altered placental oxygenation in fetal growth restricted pregnancies View pdf
  66. Endothelial layer mediated vasodilatory effect of PP13 in the uterine circulation View pdf
  67. Preeclampsia: Renalase, a novel marker View pdf
  68. The assessment of the role of VEGF-A, VEGFR-1 and TGF beta1 in pregnancy complicated by pre-eclampsia View pdf
  69. The role of Interleukin-17 and Interleukin-23 in the pathogenesis of pre-eclampsia View pdf
  70. The value of UA pulsatility index in the prediction of adverse outcome in the fetuses with PIH or PE View pdf
  71. Genetic counseling in preeclampsia View pdf
  72. Renal vascularization and fetal hemodynamics in fetuses with growth restriction View pdf
  73. Non-invasive peripheral artery tone plethysmography and intrauterine growth restriction View pdf
  74. Risk assessment for preeclampsia in first trimester: comparison of three calculation algorithms View pdf
  75. The evaluation of Nesfatin-1 levels in patients with and without intrauterine growth restriction View pdf
  76. Are we using uterine artery dopplers appropriately? A local audit experience View pdf
  77. Do Preeclamptic Symptoms Resolve After Intrauterine Death Of One Twin? View pdf
  78. Oxidative stress biomarkers and ADAMTS-12 levels in early- onset severe preeclampsia and placenta previa View pdf
172217141708169816951692169116821680166816641605156815421536153515111510150715011500149014891488148314821474146814591455143914301422141214021393138413811376137513741373137113671366136513551344133813201319131613011293129212851282127612651254124712461239123612341233123112131202119811971193119011851184117211671163
© 2016 The Fetal Medicine Foundation